Q&A: JP Morgan’s new life sciences private capital leader on the bank’s expanding ambitions, vetting startups and Abu Dhabi’s biotech push

Long­time biotech en­tre­pre­neur and in­vestor Stephen Squin­to helped build biotech gi­ants Re­gen­eron and Alex­ion be­fore mov­ing to the in­vest­ment world at Or­biMed Ad­vi­sors. Now, one year in­to his ap­point­ment as the chief in­vest­ment of­fi­cer and man­ag­ing part­ner of JP Mor­gan’s nascent Life Sci­ences Pri­vate Cap­i­tal — the firm’s first-ever ef­fort in the ear­ly-stage space — he has yet to place a bet.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.